W. Bryan Hill - 21 Nov 2024 Form 4 Insider Report for ALKAMI TECHNOLOGY, INC. (ALKT)

Signature
/s/ Douglas A. Linebarger, as Attorney-in-Fact for W. Bryan Hill
Issuer symbol
ALKT
Transactions as of
21 Nov 2024
Net transactions value
-$2,553,343
Form type
4
Filing time
22 Nov 2024, 18:02:15 UTC
Previous filing
20 Nov 2024
Next filing
26 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKT Common Stock Options Exercise $1,704,465 +110,250 +23% $15.46 581,653 21 Nov 2024 Direct
transaction ALKT Common Stock Sale $1,514,971 -39,838 -6.8% $38.03 541,815 21 Nov 2024 Direct F1
transaction ALKT Common Stock Sale $2,742,836 -70,412 -13% $38.95 471,403 21 Nov 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKT Stock Option (Right to Buy) Options Exercise $0 -110,250 -94% $0.000000 7,350 21 Nov 2024 Common Stock 110,250 $15.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $37.54 to $38.53. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $38.54 to $39.26. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The options are fully vested and exercisable.